FDA guides preferred composition and Pfizer supplies vaccine to the U.S. market.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA guides preferred composition and Pfizer supplies vaccine to the U.S. market.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- The FDA aligned vaccine formulas with global health recommendations provided by the World Health Organization.
- FDA granted approval for Pfizer's updated vaccine on September 2, 2025.
- Pfizer and Seagen are growing their older-adult vaccine market share by expanding the Prevnar 20 vaccination program and rebuilding their commercial model around acquired products.
- FDA and Pfizer are seeking regulatory approval for their products.
- A product was launched in the U.S. market following FDA involvement.